CORD-19:ceba28d8304f3df8001164f8edeef545154289f6 / 30646-30995 JSONTXT

{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T111","span":{"begin":134,"end":137},"obj":"Disease"},{"id":"T112","span":{"begin":235,"end":238},"obj":"Disease"},{"id":"T36754","span":{"begin":134,"end":137},"obj":"Disease"},{"id":"T53055","span":{"begin":235,"end":238},"obj":"Disease"}],"attributes":[{"id":"A111","pred":"mondo_id","subj":"T111","obj":"http://purl.obolibrary.org/obo/MONDO_0016318"},{"id":"A112","pred":"mondo_id","subj":"T112","obj":"http://purl.obolibrary.org/obo/MONDO_0016318"},{"id":"A23564","pred":"mondo_id","subj":"T36754","obj":"http://purl.obolibrary.org/obo/MONDO_0016318"},{"id":"A89879","pred":"mondo_id","subj":"T53055","obj":"http://purl.obolibrary.org/obo/MONDO_0016318"}],"text":"Our data together with these studies suggest that preserving and augmenting anti-JCPyV CD4 T cells or providing \"helper\" cytokines in PML-susceptible individuals, and using such interventions to supplement CD8 T cell immunotherapy for PML, could promote differentiation of brain-infiltrating CD8 T cells into CD8 bT RM and improve disease prognosis."}

{"project":"CORD-19-Sentences","denotations":[{"id":"TextSentencer_T176","span":{"begin":0,"end":349},"obj":"Sentence"},{"id":"TextSentencer_T176","span":{"begin":0,"end":349},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Our data together with these studies suggest that preserving and augmenting anti-JCPyV CD4 T cells or providing \"helper\" cytokines in PML-susceptible individuals, and using such interventions to supplement CD8 T cell immunotherapy for PML, could promote differentiation of brain-infiltrating CD8 T cells into CD8 bT RM and improve disease prognosis."}

{"project":"CORD-19-PD-UBERON","denotations":[{"id":"T94","span":{"begin":273,"end":278},"obj":"Body_part"}],"attributes":[{"id":"A94","pred":"uberon_id","subj":"T94","obj":"http://purl.obolibrary.org/obo/UBERON_0000955"}],"text":"Our data together with these studies suggest that preserving and augmenting anti-JCPyV CD4 T cells or providing \"helper\" cytokines in PML-susceptible individuals, and using such interventions to supplement CD8 T cell immunotherapy for PML, could promote differentiation of brain-infiltrating CD8 T cells into CD8 bT RM and improve disease prognosis."}